|
Home > Articles
MRI Imaging of the Prostate
Abstract
There is no set protocol for imaging prostate cancer, and a selection of a particular modality (TRUS, CT, or MRI) often depends on the equipment and local expertise available. None of the imaging modality is perfect and a judicious combination provides the best results. MR imaging and MR spectroscopic imaging are powerful new tools for the local anatomic and metabolic evaluation of prostate cancer. MRI/MRSI offers new insights into the assessment of tumor location, volume, and aggressiveness and improve staging. The techniques are novel; indications and effectiveness continue to be defined; examination is expensive and the potential role of these studies still evolving. However, with increasing patient demand for minimally invasive and patient specific treatment, it is likely that the prostate MRI and MRSI will become the recognized modality of choice for loco-regional imaging evaluation of prostate cancer.
Author
H Hricak
Contact Details
Corresponding address:
H Hricak
Department of Radiology,
Carroll and Milton Petrie Chair
Memorial Sloan-Kettering Cancer Center
Cornell University
New York
USA
Reference
ICIS Cancer Imaging Volume 2
DOI: 10.1102/1470-7330.2002.0002
Date Posted
31 July 2002
Open Access is provided for this article.
Screen PDF
Size
165.37 KB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
1 second |
ADSL 512Kb/s (Broadband): |
2 seconds |
64 Kb/s (ISDN): |
20 seconds |
33.3 Kb/s (Typical Modem): |
39 seconds |
Print PDF
Size
31.35 KB
Minimum Estimated Download Times
ADSL 2Mb/s (Broadband): |
1 second |
ADSL 512Kb/s (Broadband): |
1 second |
64 Kb/s (ISDN): |
3 seconds |
33.3 Kb/s (Typical Modem): |
7 seconds |
|
